pCPA File Number: 22384
Under consideration for negotiation
to reduce the formation of heterotopic ossification in adults and children aged 8 years and above for females and 10 years and above for males with Fibrodysplasia (myositis) Ossificans Progressiva
Ipsen Biopharmaceuticals Canada, Inc.
CADTH Project Number:
pCPA Engagement Letter Issued:
Negotiation Process Concluded: